Cancer therapy products dominating the ad pages in medical journals
There were more than 38,804 ad pages purchased in professional health journals through May 2014, a 9% decrease compared to 2013, according to Kantar Media. At the top of list are cancer therapy products, which continue to be first on the list in terms of pages and dollars. Oral diabetes products have tripled their investment (in pages) year-over-year. Through May, this product class has purchased more than 1,000 pages.
Top 5 Print Ad Drug Classes (Pages): May 2014
- Cancer Therapy Products – 3,520 pages (-9%)
- Diabetes Oral – 1,513 pages (+175%)
- Anticoagulants Oral – 1,057 pages (-40%)
- Biological Response Modifiers – 812 pages (+29%)
- Antivirals Other – 804 pages (+310%)
The percentage changes compare May 2014 to that same time period in 2013. For more information on these ad insights or other data, let one of us know.
Kantar Media sets the standard for accurate, comprehensive competitive advertising intelligence in the professional healthcare arena. Check back next month for updated data on the top products, classes, companies and category movers year-to-date.